title: Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
authors.forename: Adam
authors.initials: A
authors.lastname: Gordon
authors.forename: Solomon
authors.initials: S
authors.lastname: Menahem
authors.forename: Joanne
authors.initials: J
authors.lastname: Mitchell
authors.forename: Peter
authors.initials: P
authors.lastname: Jenkins
authors.forename: John
authors.initials: J
authors.lastname: Dowling
authors.forename: Stuart K
authors.initials: SK
authors.lastname: Roberts
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005922:Glomerulonephritis, IGA / Q000209:etiology*; D006417:Hematuria / Q000139:chemically induced; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a